Stereotaxis, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on December 28, 2009, reporting an event that occurred on December 21, 2009. The filing concerns a material definitive agreement entered into with Biosense Webster, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a contractual amendment rather than financial performance data.
Material Changes
On December 21, 2009, the Company executed a Third Amendment to the Development Alliance and Supply Agreement with Biosense Webster, Inc. Key changes include:
- Extension of Biosense Webster's exclusive distribution rights for the Company's non-irrigated catheters until May 1, 2010.
- Updates to the revenue sharing arrangement between the parties to align with the extended distribution term.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future outlook, or a discussion of risks and contingencies beyond the terms of the amended agreement.
Investor Verification Points
- Verify the specific terms of the updated revenue sharing arrangement to assess impact on future gross margins.
- Confirm the status of the Company's non-irrigated catheter product line and its reliance on Biosense Webster for distribution post-May 1, 2010.
- Review prior agreements to understand the historical context of the revenue sharing model.